clinical perspectives
Immunosuppressive therapy of autoimmune diseases

https://doi.org/10.1016/0167-5699(93)90053-NGet rights and content

Abstract

Cyclosporin: A, corticosteroids and cyclophosphamide show a remarkable efficacy in a large number of autoimmune diseases. However, their effect is dependent on continuous drug administration with potential risks of drug toxicity and over immunosuppression. Results recently obtained in animal models, particularly with anti-CD3 and anti-CD4 monoclonal antibodies, indicate that reestablishment of tolerance to self antigens is a feasible goal.

References (36)

  • I.M. Roitt

    J. Autoimmunity

    (1992)
  • J.F. Bach

    J. Autoimmunity

    (1992)
  • A.G. Alexander et al.

    Lancet

    (1992)
  • T.E. Starzl

    Lancet

    (1984)
  • G. Feutren

    Lancet

    (1986)
  • D. Goldberg

    J. Autoimmunity

    (1991)
  • D.C. Wraith et al.

    J. Autoimmunity

    (1992)
  • M. Debray-Sachs

    J. Autoimmunity

    (1991)
  • J.F. Bach et al.

    The Mode of Action of Immunosuppressive Agents

    (1985)
  • J.F. Bach et al.
  • M.C. Honeyman et al.

    Semin. Immunopathol.

    (1993)
  • L. Chatenoud et al.

    C.R. Acad Sci. Paris

    (1992)
  • P. Hutchings et al.

    Eur. J. Immunol.

    (1992)
  • Y. Mori

    Diabetologia

    (1986)
  • H.E. Rugstad et al.

    Immunopharmacology in Autoimmune Diseases and Transplantation

    (1992)
  • L. Endresen
  • H.A. Austin

    New Engl. J. Med.

    (1986)
  • A.S. Fau et al.

    Ann. Intern. Med.

    (1983)
  • Cited by (45)

    • Immunomodulatory activities of Corchorus olitorius leaf extract: Beneficial effects in macrophage and NK cell activation immunosuppressed mice

      2018, Journal of Functional Foods
      Citation Excerpt :

      Certain functional agents may act as immunostimulators and can potentially overcome the immunosuppressive adverse effects associated with cyclophosphamide (CTX) treatment. Other agents may act as immunosuppressants and can potentially be used to ameliorate hyper-immune statuses associated with some autoimmune disorders (Bach, 1993; Kim, Emi, & Tanabe, 2006). Across many East Asian clinical practices, immunomodulation is viewed as the primary target for the treatment and prevention of various diseases, including the common cold, various infections, and cancer (Ye et al., 2015).

    • The heuristics of biologic theory: The case of self-nonself discrimination

      2003, Cellular Immunology
      Citation Excerpt :

      Thus, the CST obscured the nosologic order inherent in the major clinical autoimmune diseases [17] and denied the very existence of physiological autoimmunity [18]. Moreover, the CST theory of self–nonself discrimination led to autoimmune disease therapies aimed at blocking specific self-recognition or designed to destroy self-reactive lymphocytes [19]. This therapeutic strategy, regrettably, has thus far failed.

    • Immunology of type 1 diabetes: Intervention and prevention strategies

      1999, Endocrinology and Metabolism Clinics of North America
    View all citing articles on Scopus
    View full text